SK Life Science Labs
Brian Vidal-Torres is an experienced scientist specializing in biology with a focus on drug discovery and translational medicine. Currently serving as an Associate Scientist at Proteovant Therapeutics, Brian contributes to the design and execution of innovative cell-based assays, developing methods for target identification and biomarker discovery to advance protein degraders for cancer and other therapeutic areas. Prior experience includes roles at Prelude Therapeutics, where Brian held positions as Senior Research Associate and Research Associate, emphasizing the analysis of preclinical and clinical samples and the development of assay systems. At Bristol-Myers Squibb, responsibilities involved the management of chemicals and compounds, while an early research role at the University of Puerto Rico focused on breast cancer cell research. Brian holds a Bachelor of Science in Biological Sciences from Rowan University.
This person is not in any teams
SK Life Science Labs
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-centric approach through AI enabled target identification. Our core TPD platform, built upon a strong TPD knowledge base, novel E3 ligands & linkers, and machine-learning based ternary complex modeling, is further complemented by a proprietary MOPED™ molecular glue platform. SK Life Science Labs integrates innovative platforms with deep drug-hunting expertise to defeat disease and improve patients’ lives. View our community guidelines here: http://bit.ly/3REsFKU